Speech-Language Pathologists in Albany, MN Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Haily Anderson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 230 Church Ave, Albany, MN 56307 Phone: 320-845-2195 |
Katelyn Yaroscak, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 230 Church Ave, Albany, MN 56307 Phone: 320-845-2195 |
 Samuel Gordon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 230 Church Ave, Albany, MN 56307 Phone: 320-845-2195 |
News Archive
Noven completes LDMP Phase 3 studies on menopausal VMS
Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has completed the Phase 3 clinical development program evaluating low-dose mesylate salt of paroxetine (LDMP) for the treatment of vasomotor symptoms (VMS) associated with menopause.
First Edition: May 16, 2011
Kaiser Health News staff writer Phil Galewitz reports: "Florida wants to be the first state in the nation to charge most of its Medicaid recipients a monthly premium as well as $100 for using the ER for routine care. But even supporters acknowledge that the new fees, passed recently by the state legislature as part of a sweeping Medicaid measure, face long odds getting federal approval".
China Biologic Products' fourth quarter revenue rises 185.6%
China Biologic Products, Inc., one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, operating through its indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd and Guiyang Dalin Biologic Technologies Co., Ltd. and its equity investment in Xi'an Huitian Blood Products Co., Ltd., today reported financial results for the fourth quarter and year ended December 31, 2009.
Boozing leads to small brains or people with small brains drink more?
Research has shown that excessive alcohol use is associated with reduction in brain volume. Now a new study has shown that brain volume is associated genetically with a predisposition to excessive alcohol consumption.
Verastem second quarter net loss increases to $6.8 million
Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs to treat breast and other cancers by targeting cancer stem cells, today reported financial results for the quarter ended June 30, 2012, and also commented on certain corporate accomplishments and plans.
› Verified 2 days ago
Physical Therapists
Occupational Therapists
Speech-Language Pathologists
Optometrists